Infections: all 6,702 studies

Page 13 of 68. Open to participants first (801), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated CirrhosisCompletedNCT02642432Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 InfectionCompletedNCT02640482Phase 3Results posted
• Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and CirrhosisCompletedNCT02639338Phase 3Results posted
• Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infectionCompletedNCT02637999Phase 1/2Results posted
• Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy VolunteersCompletedNCT02631954Phase 1Results posted
• Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212CompletedNCT02628600Phase 3Results posted
• Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo MicrodialysisCompletedNCT02620787Phase 1Results posted
• Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb InfectionsCompletedNCT02620774Phase 1Results posted
• Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 YearsCompletedNCT02616783Phase 3Results posted
• Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)TerminatedNCT02613403Phase 2Results posted
• Infant TB Infection Prevention StudyCompletedNCT02613169Phase 2Results posted
• Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus InfectionCompletedNCT02609659Phase 3Results posted
• Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral TherapyCompletedNCT02607800Phase 3Results posted
• Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral TherapyCompletedNCT02607735Phase 3Results posted
• Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected AdultsCompletedNCT02605954Phase 3Results posted
• Skin and Soft Tissue Infection (SSTI) StudyCompletedNCT02600871Phase 4Results posted
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic HemodialysisCompletedNCT02600819Phase 3Results posted
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile InfectionCompletedNCT02589847Phase 2Results posted
• A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) InfectionCompletedNCT02582983Phase 4Results posted
• Targeting Platelets in Chronic HIV InfectionCompletedNCT02578706Phase 2Results posted
• Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock SolutionCompletedNCT02577718Phase 1/2Results posted
• Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCTCompletedNCT02575079Not applicableResults posted
• Cross-linking for Corneal Ulcers Treatment TrialCompletedNCT02570321Phase 3Results posted
• Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint InfectionsCompletedNCT02569541Phase 2/3Results posted
• Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in WomenCompletedNCT02568215Phase 2Results posted
• A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTICompletedNCT02563106Phase 2Results posted
• Static vs. Articulating Antibiotic Spacer for Periprosthetic Joint Infection in Total Knee ArthroplastyTerminatedNCT02547129Not applicableResults posted
• Comparison of Two Rescue Therapies for Helicobacter Pylori InfectionCompletedNCT02547012Not applicableResults posted
• Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral RegimenCompletedNCT02536313Phase 2Results posted
• Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT02530515Phase 2Results posted
• ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated CirrhosisCompletedNCT02517528Phase 3Results posted
• ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT02517515Phase 3Results posted
• Skin Prep to Reduce Postoperative Shoulder InfectionCompletedNCT02510144Not applicableResults posted
• Prevena™ Incisional Negative Pressure Wound Therapy in Re-operative Colorectal SurgeryCompletedNCT02509260Not applicableResults posted
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular CarcinomaTerminatedNCT02504099Phase 3Results posted
• Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)CompletedNCT02497781Phase 2Results posted
• A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract InfectionCompletedNCT02491684Phase 2Results posted
• 2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery PatientsCompletedNCT02490631Phase 3Results posted
• Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney DiseaseCompletedNCT02487199Phase 3Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV InfectionCompletedNCT02487030Phase 3Results posted
• Prevention of Post-operative Urinary RetentionCompletedNCT02486653Phase 3Results posted
• A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)CompletedNCT02486627Phase 3Results posted
• A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric SubjectsCompletedNCT02486406Phase 2/3Results posted
• Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult VolunteersCompletedNCT02478463Phase 1Results posted
• Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).CompletedNCT02475733Phase 2Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV InfectionCompletedNCT02472886Phase 3Results posted
• Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue InfectionsCompletedNCT02469857Phase 3Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-InfectionCompletedNCT02457611Phase 2Results posted
• Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis VaccineCompletedNCT02453048Phase 1Results posted
• A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)CompletedNCT02452918Phase 4Results posted
• Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)CompletedNCT02452047Phase 3Results posted
• Continuous Antibiotic Prophylaxis in Colorectal SurgeryCompletedNCT02445859Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in BrazilCompletedNCT02442271Phase 3Results posted
• Study of Debio 1450 for Bacterial Skin InfectionsCompletedNCT02426918Phase 2Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 InfectionCompletedNCT02413593Phase 2Results posted
• The Influence of Antibiotic Prophylaxis on Intraoperative Prosthetic Joint Infection CulturesCompletedNCT02413034Not applicableResults posted
• A Safety and Immune Response Study of 2 Experimental HIV VaccinesCompletedNCT02404311Phase 1/2Results posted
• STRIPES Study: Study To Reduce Infection Post cEsarean SectionCompletedNCT02402907Not applicableResults posted
• Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected AdultsCompletedNCT02399345Phase 3Results posted
• Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile InfectionTerminatedNCT02395848Phase 3Results posted
• Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117)CompletedNCT02387983Phase 1Results posted
• Use of 2% Chlorhexidine Cloths Reduce Surgical Site InfectionsCompletedNCT02385708Not applicableResults posted
• Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV InfectionCompletedNCT02384395Not applicableResults posted
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV InfectionCompletedNCT02378961Phase 2Results posted
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV InfectionCompletedNCT02378935Phase 2Results posted
• Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)CompletedNCT02378480Phase 3Results posted
• Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial)TerminatedNCT02374853Phase 2Results posted
• Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola InfectionCompletedNCT02363322Phase 1/2Results posted
• Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori InfectionCompletedNCT02359435Not applicableResults posted
• Short-course Methenamine Hippurate for Prevention of Post-operative UTICompletedNCT02358993Not applicableResults posted
• Effects of Antibiotic Prophylaxis on Recurrent UTI in ChildrenCompletedNCT02357758Phase 4Results posted
• A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus InfectionCompletedNCT02356562Phase 2Results posted
• Lubricant Investigation in Men to Inhibit Transmission of HPV InfectionTerminatedNCT02354144Phase 2/3Results posted
• Community Central Line Infection Prevention TrialCompletedNCT02351258Not applicableResults posted
• Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant RecipientsCompletedNCT02351180Phase 1/2Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation SettingCompletedNCT02350569Phase 2Results posted
• Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 InfectionCompletedNCT02349048Phase 2Results posted
• Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV InfectionCompletedNCT02346721Phase 3Results posted
• Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen AloneCompletedNCT02344004Phase 3Results posted
• Changes in Exhaled 13CO2/12CO2 Breath Delta Value as an Early Indicator of Infection in ICU PatientsCompletedNCT02327130Not applicableResults posted
• Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm InfantsCompletedNCT02325791Phase 3Results posted
• A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract InfectionsCompletedNCT02321800Phase 2Results posted
• FMT for Multidrug Resistant Organism ReversalCompletedNCT02312986Phase 1Results posted
• Multi-Center Study of New Medications to Treat Vaginal InfectionsCompletedNCT02308046Phase 3Results posted
• Multi-Center Study of New Medications to Treat Vaginal InfectionsCompletedNCT02308033Phase 3Results posted
• Multi-Center Study of New Medications to Treat Vaginal InfectionsCompletedNCT02308007Phase 3Results posted
• An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract InfectionsTerminatedNCT02302092Phase 3Results posted
• Comparative Effectiveness of Antibiotics for Respiratory InfectionsCompletedNCT02297815Results posted
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus InfectionCompletedNCT02292719Phase 2Results posted
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C InfectionTerminatedNCT02292706Results posted
• Topical Vancomycin for Neurosurgery Wound ProphylaxisCompletedNCT02284126Phase 3Results posted
• MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy ParticipantsTerminatedNCT02281344Phase 1Results posted
• World-wide Randomized Antibiotic Envelope Infection Prevention TrialCompletedNCT02277990Phase 4Results posted
• Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)CompletedNCT02276482Phase 3Results posted
• Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent VaccineCompletedNCT02270944Phase 2Results posted
• MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure InfectionCompletedNCT02269319Phase 2Results posted
• Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)CompletedNCT02266706Phase 1Results posted
• FMT Versus Antimicrobials for Initial Treatment of Recurrent CDITerminatedNCT02255305Phase 2Results posted
• Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory TractCompletedNCT02254421Phase 2Results posted
• Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory TractCompletedNCT02254408Phase 2Results posted

← Infections overview